LOTUSEYE — Lotus Eye Hospital and Institute Income Statement
0.000.00%
Last trade - 00:00
- IN₹1.25bn
- IN₹1.16bn
- IN₹470.44m
- 51
- 23
- 20
- 17
2019 March 31st | 2020 March 31st | 2021 March 31st | 2022 March 31st | 2023 March 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 384 | 406 | 324 | 389 | 470 |
Cost of Revenue | |||||
Gross Profit | 207 | 221 | 172 | 206 | 251 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 384 | 392 | 311 | 356 | 424 |
Operating Profit | 0.146 | 13.2 | 12.3 | 33.6 | 46.1 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 6.28 | 14.6 | 19.9 | 40.9 | 56.5 |
Provision for Income Taxes | |||||
Net Income After Taxes | 7.08 | 10.6 | 15.7 | 29.8 | 40.8 |
Net Income Before Extraordinary Items | |||||
Net Income | 7.08 | 10.6 | 15.7 | 29.8 | 40.8 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 7.08 | 10.6 | 15.7 | 29.8 | 40.8 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.422 | 0.755 | 0.723 | 1.44 | 1.96 |
Dividends per Share |